Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Surg Res. 2021 Apr 8;264:230–235. doi: 10.1016/j.jss.2021.02.035

Table 5 –

RAIa Therapy and outcomes for patients with cN0b papillary thyroid carcinoma.

Post operation Data CND(+)c CND(−)c P value
Adjuvant RAI Therapy - Given 46% 34% 0.268
 Evidence of Recurrence or Distant Metastasis 7% 8% 0.855
 Evidence of Persistent Disease 7% 10% 0.614
Adjuvant RAI Therapy - Not Given 31% 33%
 Evidence of Recurrence or Distant Metastasis 16% 1% < 0.001
 Evidence of Persistent Disease 16% 2% 0.009
Adjuvant RAI Therapy - Unknown 23% 33%
a

RAI = radioactive iodine

b

cN0 = no clinically-evident nodal metastasis

c

CND = central neck dissection